Skip to main content
Top
Published in: Tumor Biology 3/2014

01-03-2014 | Research Article

Part I—mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways

Authors: Madeeha Aqil, Kim M. Elseth, Benjamin J. Vesper, Zane Deliu, Bulent Aydogan, Jiaping Xue, James A. Radosevich

Published in: Tumor Biology | Issue 3/2014

Login to get access

Abstract

Our previous studies demonstrate that A549, a human lung adenocarcinoma line, could be adapted to the free radical nitric oxide (NO). NO has been shown to be overexpressed in human tumors. The original cell line, A549 (parent), and the newly adapted A549-HNO (which has a more aggressive phenotype) serves as a useful model system to study the role of NO in tumor biology. It is well known that DNA damage response (DDR) is altered in cancer cells and NO is known to cause DNA damage. Modulations in molecular mechanisms involved in DNA damage response in A549-HNO cells can provide better insights into the enhanced growth behavior of these cells. Thus, here, we carried out a series of time course experiments by treating A549 and A549-HNO cells with NO donor and examining levels of proteins involved in the DDR pathway. We observed induced expression of key components of DDR pathway in A549-HNO cells. The HNO cells showed sustained expression of key proteins involved in both nonhomologous end joining (NHEJ) and homologous recombination pathways, whereas parent cells only expressed low levels of NHEJ pathway proteins. Further with prolonged NO exposure, ATR, Chk1, and p53 were activated and upregulated in HNO cells. Activation of p53 results in inhibition of apoptosis through induced Mcl1 expression. It also leads to cell cycle modulation. Interestingly, several reports show that cancer stem cells have enhanced expression of proteins involved in DNA damage response and also activated an antiapoptotic response. Our results here suggest that our HNO adapted A549 cells have increased activation of DNA damage response pathway proteins which can lead to better DNA repair function. Enhanced DDR leads to activation of antiapoptosis response and modulation in the cell cycle which may lead to better survival of these cells under harsh conditions. Thus, our present investigation further supports the hypothesis that HNO exposure leads to survival of these cells.
Literature
1.
go back to reference Paradise WA, Vesper BJ, Goel A, Waltonen JD, Altman KW, Haines GK, et al. Nitric oxide: perspectives and emerging studies of a well known cytotoxin. Int J Mol Sci. 2010;11(7):2715–45.PubMedCentralPubMedCrossRef Paradise WA, Vesper BJ, Goel A, Waltonen JD, Altman KW, Haines GK, et al. Nitric oxide: perspectives and emerging studies of a well known cytotoxin. Int J Mol Sci. 2010;11(7):2715–45.PubMedCentralPubMedCrossRef
2.
go back to reference Hirst D, Robson T. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Curr Pharm Des. 2010;16(4):411–20.PubMedCrossRef Hirst D, Robson T. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Curr Pharm Des. 2010;16(4):411–20.PubMedCrossRef
3.
go back to reference Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis. 2013;34(3):503–12.PubMedCrossRef Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis. 2013;34(3):503–12.PubMedCrossRef
4.
go back to reference Mashimo H, Goyal RK. Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol. 1999;277(4 Pt 1):G745–50.PubMed Mashimo H, Goyal RK. Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol. 1999;277(4 Pt 1):G745–50.PubMed
5.
go back to reference Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006;8(7–8):1329–37.PubMedCrossRef Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006;8(7–8):1329–37.PubMedCrossRef
6.
go back to reference Kots AY, Martin E, Sharina IG, Murad F. A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Handb Exp Pharmacol. 2009;191:1–14.PubMedCrossRef Kots AY, Martin E, Sharina IG, Murad F. A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Handb Exp Pharmacol. 2009;191:1–14.PubMedCrossRef
7.
go back to reference Ridnour LA, Sim JE, Choi J, Dickinson DA, Forman HJ, Ahmad IM, et al. Nitric oxide-induced resistance to hydrogen peroxide stress is a glutamate cysteine ligase activity-dependent process. Free Radic Biol Med. 2005;38(10):1361–71.PubMedCrossRef Ridnour LA, Sim JE, Choi J, Dickinson DA, Forman HJ, Ahmad IM, et al. Nitric oxide-induced resistance to hydrogen peroxide stress is a glutamate cysteine ligase activity-dependent process. Free Radic Biol Med. 2005;38(10):1361–71.PubMedCrossRef
8.
go back to reference Lee TW, Chen GG, Xu H, Yip JH, Chak EC, Mok TS, et al. Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma. Eur J Cancer. 2003;39(9):1296–301.PubMedCrossRef Lee TW, Chen GG, Xu H, Yip JH, Chak EC, Mok TS, et al. Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma. Eur J Cancer. 2003;39(9):1296–301.PubMedCrossRef
9.
go back to reference Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res. 2000;6(12):4739–44.PubMed Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res. 2000;6(12):4739–44.PubMed
10.
go back to reference Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and upregulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer. 1998;78(4):534–41.PubMedCentralPubMedCrossRef Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and upregulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer. 1998;78(4):534–41.PubMedCentralPubMedCrossRef
11.
go back to reference Masri FA, Comhair SA, Koeck T, Xu W, Janocha A, Ghosh S, et al. Abnormalities in nitric oxide and its derivatives in lung cancer. Am J Respir Crit Care Med. 2005;172(5):597–605.PubMedCentralPubMedCrossRef Masri FA, Comhair SA, Koeck T, Xu W, Janocha A, Ghosh S, et al. Abnormalities in nitric oxide and its derivatives in lung cancer. Am J Respir Crit Care Med. 2005;172(5):597–605.PubMedCentralPubMedCrossRef
12.
go back to reference Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, et al. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn J Cancer Res. 1998;89(7):696–702.PubMedCrossRef Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, et al. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn J Cancer Res. 1998;89(7):696–702.PubMedCrossRef
13.
go back to reference Bentz BG, Chandra R, Haines 3rd GK, Robinson AM, Shah P, Radosevich JA. Nitric oxide and apoptosis during human head and neck squamous cell carcinoma development. Am J Otolaryngol. 2002;23(1):4–11.PubMedCrossRef Bentz BG, Chandra R, Haines 3rd GK, Robinson AM, Shah P, Radosevich JA. Nitric oxide and apoptosis during human head and neck squamous cell carcinoma development. Am J Otolaryngol. 2002;23(1):4–11.PubMedCrossRef
14.
go back to reference Bentz BG, Haines 3rd GK, Radosevich JA. Increased protein nitrosylation in head and neck squamous cell carcinogenesis. Head Neck. 2000;22(1):64–70.PubMedCrossRef Bentz BG, Haines 3rd GK, Radosevich JA. Increased protein nitrosylation in head and neck squamous cell carcinogenesis. Head Neck. 2000;22(1):64–70.PubMedCrossRef
15.
go back to reference Bentz BG, Haines 3rd GK, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary tissue. Head Neck. 1998;20(4):304–9.PubMedCrossRef Bentz BG, Haines 3rd GK, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary tissue. Head Neck. 1998;20(4):304–9.PubMedCrossRef
16.
go back to reference Bentz BG, Haines 3rd GK, Lingen MW, Pelzer HJ, Hanson DG, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108(8):781–7.PubMed Bentz BG, Haines 3rd GK, Lingen MW, Pelzer HJ, Hanson DG, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108(8):781–7.PubMed
17.
go back to reference Vesper BJ, Elseth KM, Tarjan G, Haines 3rd GK, Radosevich JA. Long-term adaptation of lung tumor cell lines with increasing concentrations of nitric oxide donor. Open Lung Cancer J. 2009;2:35–44.CrossRef Vesper BJ, Elseth KM, Tarjan G, Haines 3rd GK, Radosevich JA. Long-term adaptation of lung tumor cell lines with increasing concentrations of nitric oxide donor. Open Lung Cancer J. 2009;2:35–44.CrossRef
18.
go back to reference Vesper BJ, Elseth KM, Tarjan G, Haines 3rd GK, Radosevich JA. Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide. Tumour Biol. 2010;31(4):267–75.PubMedCrossRef Vesper BJ, Elseth KM, Tarjan G, Haines 3rd GK, Radosevich JA. Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide. Tumour Biol. 2010;31(4):267–75.PubMedCrossRef
19.
go back to reference Yarmolyuk YR, Vesper BJ, Paradise WA, Elseth KM, Tarjan G, Haines 3rd GK, et al. Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines. Tumour Biol. 2011;32(1):77–85.PubMedCrossRef Yarmolyuk YR, Vesper BJ, Paradise WA, Elseth KM, Tarjan G, Haines 3rd GK, et al. Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines. Tumour Biol. 2011;32(1):77–85.PubMedCrossRef
20.
go back to reference Cubillos-Rojas M, Amair-Pinedo F, Tato I, Bartrons R, Ventura F, Rosa JL. Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris-acetate polyacrylamide gels. Electrophoresis. 2010;31(8):1318–21.PubMedCrossRef Cubillos-Rojas M, Amair-Pinedo F, Tato I, Bartrons R, Ventura F, Rosa JL. Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris-acetate polyacrylamide gels. Electrophoresis. 2010;31(8):1318–21.PubMedCrossRef
21.
go back to reference Tarjan G, Haines 3rd GK, Vesper BJ, Xue J, Altman MB, Yarmolyuk YR, et al. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumour Biol. 2011;32(1):87–98.PubMedCrossRef Tarjan G, Haines 3rd GK, Vesper BJ, Xue J, Altman MB, Yarmolyuk YR, et al. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumour Biol. 2011;32(1):87–98.PubMedCrossRef
22.
go back to reference Smyth GK, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W. Limma: Linear models for microarray data. Bioinforma Comput Biol Solutions Bioconductor 2005:397–420. Smyth GK, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W. Limma: Linear models for microarray data. Bioinforma Comput Biol Solutions Bioconductor 2005:397–420.
23.
go back to reference Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, et al. A comparison of background correction methods for two-color microarrays. Bioinformatics (Oxford, England). 2007;23(20):2700–7.CrossRef Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, et al. A comparison of background correction methods for two-color microarrays. Bioinformatics (Oxford, England). 2007;23(20):2700–7.CrossRef
24.
go back to reference Smyth GK, Speed T. Normalization of cDNA microarray data. Methods (San Diego, Calif). 2003;31(4):265–73.CrossRef Smyth GK, Speed T. Normalization of cDNA microarray data. Methods (San Diego, Calif). 2003;31(4):265–73.CrossRef
25.
go back to reference Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3: Article3. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3: Article3.
26.
go back to reference De Vitto H, Mendonca BS, Elseth KM, Onul A, Xue J, Vesper BJ, et al. Part III. Molecular changes induced by high nitric oxide adaptation in human breast cancer cell line BT-20 (BT-20-HNO): a switch from aerobic to anaerobic metabolism. Tumour Biol. 2013;34(1):403–13.PubMedCrossRef De Vitto H, Mendonca BS, Elseth KM, Onul A, Xue J, Vesper BJ, et al. Part III. Molecular changes induced by high nitric oxide adaptation in human breast cancer cell line BT-20 (BT-20-HNO): a switch from aerobic to anaerobic metabolism. Tumour Biol. 2013;34(1):403–13.PubMedCrossRef
27.
go back to reference Birnboim HC, Jevcak JJ. Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Res. 1981;41(5):1889–92.PubMed Birnboim HC, Jevcak JJ. Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Res. 1981;41(5):1889–92.PubMed
28.
go back to reference Wang C, Lees-Miller SP. Detection and repair of ionizing radiation-induced DNA double-strand breaks: New developments in nonhomologous end joining. Int J Radiat Oncol Biol Phys 2013. Wang C, Lees-Miller SP. Detection and repair of ionizing radiation-induced DNA double-strand breaks: New developments in nonhomologous end joining. Int J Radiat Oncol Biol Phys 2013.
29.
go back to reference Tobias F, Lob D, Lengert N, Durante M, Drossel B, Taucher-Scholz G, et al. Spatiotemporal dynamics of early DNA damage response proteins on complex DNA lesions. PLoS One. 2013;8(2):e57953.PubMedCentralPubMedCrossRef Tobias F, Lob D, Lengert N, Durante M, Drossel B, Taucher-Scholz G, et al. Spatiotemporal dynamics of early DNA damage response proteins on complex DNA lesions. PLoS One. 2013;8(2):e57953.PubMedCentralPubMedCrossRef
31.
go back to reference Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47(4):497–510.PubMedCrossRef Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47(4):497–510.PubMedCrossRef
32.
go back to reference Murray JM, Stiff T, Jeggo PA. DNA double-strand break repair within heterochromatic regions. Biochem Soc Trans. 2012;40(1):173–8.PubMedCrossRef Murray JM, Stiff T, Jeggo PA. DNA double-strand break repair within heterochromatic regions. Biochem Soc Trans. 2012;40(1):173–8.PubMedCrossRef
33.
go back to reference Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73–112.PubMedCrossRef Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73–112.PubMedCrossRef
34.
go back to reference Poehlmann A, Roessner A. Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract. 2010;206(9):591–601.PubMedCrossRef Poehlmann A, Roessner A. Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract. 2010;206(9):591–601.PubMedCrossRef
35.
go back to reference Mirzayans R, Andrais B, Scott A, Murray D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol. 2012;2012:170325.PubMedCentralPubMedCrossRef Mirzayans R, Andrais B, Scott A, Murray D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol. 2012;2012:170325.PubMedCentralPubMedCrossRef
36.
go back to reference Bentz BG, Hammer ND, Radosevich JA, Haines 3rd GK. Nitrosative stress induces DNA strand breaks but not caspase mediated apoptosis in a lung cancer cell line. J Carcinog. 2004;3(1):16.PubMedCentralPubMedCrossRef Bentz BG, Hammer ND, Radosevich JA, Haines 3rd GK. Nitrosative stress induces DNA strand breaks but not caspase mediated apoptosis in a lung cancer cell line. J Carcinog. 2004;3(1):16.PubMedCentralPubMedCrossRef
37.
go back to reference Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, et al. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis. PLoS One. 2013;8(2):e56381.PubMedCentralPubMedCrossRef Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, et al. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis. PLoS One. 2013;8(2):e56381.PubMedCentralPubMedCrossRef
38.
go back to reference Surova O, Zhivotovsky B. Various modes of cell death induced by DNA damage. Oncogene 2012. Surova O, Zhivotovsky B. Various modes of cell death induced by DNA damage. Oncogene 2012.
39.
go back to reference Onul A, Elseth KM, De Vitto H, Paradise WA, Vesper BJ, Tarjan G, et al. Long-term adaptation of the human lung tumor cell line A549 to increasing concentrations of hydrogen peroxide. Tumour Biol. 2012;33(3):739–48.PubMedCrossRef Onul A, Elseth KM, De Vitto H, Paradise WA, Vesper BJ, Tarjan G, et al. Long-term adaptation of the human lung tumor cell line A549 to increasing concentrations of hydrogen peroxide. Tumour Biol. 2012;33(3):739–48.PubMedCrossRef
40.
go back to reference Vesper BJ, Onul A, Haines 3rd GK, Tarjan G, Xue J, Elseth KM, et al. Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines. Tumour Biol. 2013;34(1):203–14.PubMedCrossRef Vesper BJ, Onul A, Haines 3rd GK, Tarjan G, Xue J, Elseth KM, et al. Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines. Tumour Biol. 2013;34(1):203–14.PubMedCrossRef
41.
go back to reference Liu J, Majumdar A, Thompson LH, Seidman MM. Sequence conversion by single strand oligonucleotide donors via non-homologous end joining in mammalian cells. J Biol Chem. 2010;285(30):23198–207.PubMedCentralPubMedCrossRef Liu J, Majumdar A, Thompson LH, Seidman MM. Sequence conversion by single strand oligonucleotide donors via non-homologous end joining in mammalian cells. J Biol Chem. 2010;285(30):23198–207.PubMedCentralPubMedCrossRef
42.
go back to reference Langerak P, Mejia-Ramirez E, Limbo O, Russell P. Release of Ku and MRN from DNA ends by Mre11 nuclease activity and Ctp1 is required for homologous recombination repair of double-strand breaks. PLoS Genet. 2011;7(9):e1002271.PubMedCentralPubMedCrossRef Langerak P, Mejia-Ramirez E, Limbo O, Russell P. Release of Ku and MRN from DNA ends by Mre11 nuclease activity and Ctp1 is required for homologous recombination repair of double-strand breaks. PLoS Genet. 2011;7(9):e1002271.PubMedCentralPubMedCrossRef
43.
go back to reference Kuroda S, Urata Y, Fujiwara T. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization. Acta Med Okayama. 2012;66(2):83–92.PubMed Kuroda S, Urata Y, Fujiwara T. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization. Acta Med Okayama. 2012;66(2):83–92.PubMed
44.
go back to reference Langerak P, Russell P. Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos Trans R Soc Lond B Biol Sci. 2011;366(1584):3562–71.PubMedCentralPubMedCrossRef Langerak P, Russell P. Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos Trans R Soc Lond B Biol Sci. 2011;366(1584):3562–71.PubMedCentralPubMedCrossRef
45.
go back to reference Serrano MA, Li Z, Dangeti M, Musich PR, Patrick S, Roginskaya M, Cartwright B, Zou Y. DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair. Oncogene 2012. Serrano MA, Li Z, Dangeti M, Musich PR, Patrick S, Roginskaya M, Cartwright B, Zou Y. DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair. Oncogene 2012.
46.
go back to reference Stiff T, Walker SA, Cerosaletti K, Goodarzi AA, Petermann E, Concannon P, et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 2006;25(24):5775–82.PubMedCentralPubMedCrossRef Stiff T, Walker SA, Cerosaletti K, Goodarzi AA, Petermann E, Concannon P, et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 2006;25(24):5775–82.PubMedCentralPubMedCrossRef
47.
go back to reference Riches LC, Lynch AM, Gooderham NJ. Early events in the mammalian response to DNA double-strand breaks. Mutagenesis. 2008;23(5):331–9.PubMedCrossRef Riches LC, Lynch AM, Gooderham NJ. Early events in the mammalian response to DNA double-strand breaks. Mutagenesis. 2008;23(5):331–9.PubMedCrossRef
48.
go back to reference Nakamura AJ, Rao VA, Pommier Y, Bonner WM. The complexity of phosphorylated H2AX foci formation and DNA repair assembly at DNA double-strand breaks. Cell Cycle. 2010;9(2):389–97.PubMedCentralPubMedCrossRef Nakamura AJ, Rao VA, Pommier Y, Bonner WM. The complexity of phosphorylated H2AX foci formation and DNA repair assembly at DNA double-strand breaks. Cell Cycle. 2010;9(2):389–97.PubMedCentralPubMedCrossRef
49.
go back to reference Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res. 2005;3(10):531–9.PubMedCrossRef Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res. 2005;3(10):531–9.PubMedCrossRef
50.
go back to reference Madeeha Aqil ZD, Kim M. Elseth, Grace Shen, Jiaping Xue, and James A. Radosevich. Part II Mechanism of Adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints. Tumor Biol 2013. Madeeha Aqil ZD, Kim M. Elseth, Grace Shen, Jiaping Xue, and James A. Radosevich. Part II Mechanism of Adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints. Tumor Biol 2013.
51.
go back to reference Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the mitochondria: AKTing on apoptosis. Cell Signal. 2008;20(1):21–30.PubMedCrossRef Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the mitochondria: AKTing on apoptosis. Cell Signal. 2008;20(1):21–30.PubMedCrossRef
52.
go back to reference Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A. 1995;92(10):4392–6.PubMedCentralPubMedCrossRef Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A. 1995;92(10):4392–6.PubMedCentralPubMedCrossRef
53.
go back to reference Epperlein MM, Nourooz-Zadeh J, Noronha-Dutra AA, Woolf N. Nitric oxide in cigarette smoke as a mediator of oxidative damage. Int J Exp Pathol. 1996;77(5):197–200.PubMedCentralPubMedCrossRef Epperlein MM, Nourooz-Zadeh J, Noronha-Dutra AA, Woolf N. Nitric oxide in cigarette smoke as a mediator of oxidative damage. Int J Exp Pathol. 1996;77(5):197–200.PubMedCentralPubMedCrossRef
54.
go back to reference Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995;93(1):17–48.PubMedCrossRef Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995;93(1):17–48.PubMedCrossRef
55.
go back to reference Hardcastle IR, Cockcroft X, Curtin NJ, El-Murr MD, Leahy JJ, Stockley M, et al. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem. 2005;48(24):7829–46.PubMedCrossRef Hardcastle IR, Cockcroft X, Curtin NJ, El-Murr MD, Leahy JJ, Stockley M, et al. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem. 2005;48(24):7829–46.PubMedCrossRef
56.
go back to reference Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res. 2005;65(12):4987–92.PubMedCrossRef Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res. 2005;65(12):4987–92.PubMedCrossRef
57.
go back to reference Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ, et al. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 2006;66(10):5354–62.PubMedCrossRef Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ, et al. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 2006;66(10):5354–62.PubMedCrossRef
58.
go back to reference Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12(12):801–17.PubMedCrossRef Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12(12):801–17.PubMedCrossRef
Metadata
Title
Part I—mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways
Authors
Madeeha Aqil
Kim M. Elseth
Benjamin J. Vesper
Zane Deliu
Bulent Aydogan
Jiaping Xue
James A. Radosevich
Publication date
01-03-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1318-6

Other articles of this Issue 3/2014

Tumor Biology 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine